| Superior Hospice Of Mcallen Llc 2108 S M Street Suite 8c, Mcallen, TX, 78503 | |
| (956) 878-1636 |
News Archive
The accelerated approval of the drug clofarabine to treat relapsed or refractory pediatric acute lymphoblastic leukemia (ALL) demonstrates the importance of offering children rapid access to new treatments through clinical trials, according to investigators at St. Jude Children's Research Hospital. Refractory or relapsed ALL is a disease that resists treatment.
Patients with morbid obesity are at nearly twice the risk of developing complications after spinal fusion surgery, reports a study in the May 15 issue of Spine.
BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials.
A poster from Sunnybrook Health Sciences Centre entitled "Innovative Technology Conserves Resources and Generates Savings: A Case Study from the Sunnybrook Regional Processing Centre" was voted Best Overall Poster by delegates attending the 2010 CADTH Symposium in Halifax, Nova Scotia.
› Verified 9 days ago
| Name | Superior Hospice Of Mcallen Llc |
|---|---|
| Location | 2108 S M Street Suite 8c, Mcallen, Texas |
| Hospice ID | 671743 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Partnership |
| Profit Type | FOR PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 650 |
News Archive
The accelerated approval of the drug clofarabine to treat relapsed or refractory pediatric acute lymphoblastic leukemia (ALL) demonstrates the importance of offering children rapid access to new treatments through clinical trials, according to investigators at St. Jude Children's Research Hospital. Refractory or relapsed ALL is a disease that resists treatment.
Patients with morbid obesity are at nearly twice the risk of developing complications after spinal fusion surgery, reports a study in the May 15 issue of Spine.
BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials.
A poster from Sunnybrook Health Sciences Centre entitled "Innovative Technology Conserves Resources and Generates Savings: A Case Study from the Sunnybrook Regional Processing Centre" was voted Best Overall Poster by delegates attending the 2010 CADTH Symposium in Halifax, Nova Scotia.
› Verified 9 days ago
| NPI Number | 1407144199 |
| Organization Name | Superior Hospice Of Mcallen Llc |
| Address | 2108 S M St Ste 8c Mcallen, Texas, 78503 |
| Phone Number | (956)878-1636 |
News Archive
The accelerated approval of the drug clofarabine to treat relapsed or refractory pediatric acute lymphoblastic leukemia (ALL) demonstrates the importance of offering children rapid access to new treatments through clinical trials, according to investigators at St. Jude Children's Research Hospital. Refractory or relapsed ALL is a disease that resists treatment.
Patients with morbid obesity are at nearly twice the risk of developing complications after spinal fusion surgery, reports a study in the May 15 issue of Spine.
BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials.
A poster from Sunnybrook Health Sciences Centre entitled "Innovative Technology Conserves Resources and Generates Savings: A Case Study from the Sunnybrook Regional Processing Centre" was voted Best Overall Poster by delegates attending the 2010 CADTH Symposium in Halifax, Nova Scotia.
› Verified 9 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 95.9 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 95.9 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 95.9 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 87.0 | 93.3 |
News Archive
The accelerated approval of the drug clofarabine to treat relapsed or refractory pediatric acute lymphoblastic leukemia (ALL) demonstrates the importance of offering children rapid access to new treatments through clinical trials, according to investigators at St. Jude Children's Research Hospital. Refractory or relapsed ALL is a disease that resists treatment.
Patients with morbid obesity are at nearly twice the risk of developing complications after spinal fusion surgery, reports a study in the May 15 issue of Spine.
BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials.
A poster from Sunnybrook Health Sciences Centre entitled "Innovative Technology Conserves Resources and Generates Savings: A Case Study from the Sunnybrook Regional Processing Centre" was voted Best Overall Poster by delegates attending the 2010 CADTH Symposium in Halifax, Nova Scotia.
› Verified 9 days ago
| Home Health Aides | 1 |
| Counselors | 1 |
| Licensed Practical or Vocational Nurses | 2 |
| Medical Social Workers | 1 |
| Registered Nurses | 2 |
| Other Personnel | 1 |
| Total Employees | 8 |
|---|
News Archive
The accelerated approval of the drug clofarabine to treat relapsed or refractory pediatric acute lymphoblastic leukemia (ALL) demonstrates the importance of offering children rapid access to new treatments through clinical trials, according to investigators at St. Jude Children's Research Hospital. Refractory or relapsed ALL is a disease that resists treatment.
Patients with morbid obesity are at nearly twice the risk of developing complications after spinal fusion surgery, reports a study in the May 15 issue of Spine.
BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials.
A poster from Sunnybrook Health Sciences Centre entitled "Innovative Technology Conserves Resources and Generates Savings: A Case Study from the Sunnybrook Regional Processing Centre" was voted Best Overall Poster by delegates attending the 2010 CADTH Symposium in Halifax, Nova Scotia.
› Verified 9 days ago
| Others | 0.13 |
| Total Volunteers | 0.13 |
|---|
News Archive
The accelerated approval of the drug clofarabine to treat relapsed or refractory pediatric acute lymphoblastic leukemia (ALL) demonstrates the importance of offering children rapid access to new treatments through clinical trials, according to investigators at St. Jude Children's Research Hospital. Refractory or relapsed ALL is a disease that resists treatment.
Patients with morbid obesity are at nearly twice the risk of developing complications after spinal fusion surgery, reports a study in the May 15 issue of Spine.
BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials.
A poster from Sunnybrook Health Sciences Centre entitled "Innovative Technology Conserves Resources and Generates Savings: A Case Study from the Sunnybrook Regional Processing Centre" was voted Best Overall Poster by delegates attending the 2010 CADTH Symposium in Halifax, Nova Scotia.
› Verified 9 days ago
| Iph Hospice Care Inc Location: 1100 E Jasmine Ave Suite 203, Mcallen, Texas, 78501 Phone: (956) 878-1636 |
| Pax Villa Hospice And Palliative Care Location: 4513 W. Business Hwy 83, Mcallen, Texas, 78502 Phone: (956) 878-1636 |
| Gracia Hospice Care Location: 717 East Esperanza Avenue, Mcallen, Texas, 78501 Phone: (956) 878-1636 |
| Only Love Hospice Location: 833 E Esperanza Avenue Suite A, Mcallen, Texas, 78501 Phone: (956) 878-1636 |